Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Covington
Medtronic
Accenture
McKinsey
Express Scripts

Generated: September 16, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,982,043

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 7,982,043 protect, and when does it expire?

Patent 7,982,043 protects NERLYNX and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 7,982,043
Title:Protein tyrosine kinase enzyme inhibitors
Abstract: This invention provides compounds of formula 1, having the structure ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are described within the specification.
Inventor(s): Wissner; Allan (Ardsley, NY), Rabindran; Sridhar Krishna (Chestnut Ridge, NY), Tsou; Hwei-Ru (New City, NY)
Assignee: Wyeth LLC (Madison, NJ)
Application Number:12/136,357
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 7,982,043

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Puma Biotech NERLYNX neratinib maleate TABLET;ORAL 208051-001 Jul 17, 2017 RX Yes Yes   Try a Free Trial   Try a Free Trial EXTENDED ADJUVANT TREATMENT OF ADULT PATIENTS WITH EARLY STAGE HER2-OVEREXPRESSED/AMPLIFIED BREAST CANCER, TO FOLLOW ADJUVANT TRASTUZUMAB BASE THERAPY   Try a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Chinese Patent Office
Merck
Harvard Business School
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.